Hedge Fund Passport Capital’s Favorite 6 Healthcare Stocks

Wall St. Watchdog reveals information regarding Passport Capital’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 6 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $208.559 million.

  • Thoratec Corp. (NASDAQ:THOR): On 06/30/2011, Passport Capital reported holding 2,757,600 shares with a market value of $90,504,431. This comprised 5.73% of the total portfolio. On 09/30/2011, Passport Capital reported holding 2,568,200 shares with a market value of $83,826,046. This comprised 5.9% of the total portfolio. The net change in shares for this position over the two quarters is -189,400. About Company: Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company’s products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.
  • Vivus Inc. (NASDAQ:VVUS): On 06/30/2011, Passport Capital reported holding 4,311,600 shares with a market value of $35,096,425. This comprised 2.22% of the total portfolio. On 09/30/2011, Passport Capital reported holding 4,324,300 shares with a market value of $34,897,100. This comprised 2.46% of the total portfolio. The net change in shares for this position over the two quarters is 12,700. About Company: VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
  • Hca Hldgs Inc Com (NYSE:HCA): On 06/30/2011, Passport Capital reported holding 0 shares. On 09/30/2011, Passport Capital reported holding 1,182,700 shares with a market value of $23,843,232. This comprised 1.68% of the total portfolio. The net change in shares for this position over the two quarters is 1,182,700. About Company: HCA Holdings, Inc. operates hospitals. The Company operates acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. HCA operates hospitals in the United States and the United Kingdom.
  • Alkermes Inc. (NASDAQ:ALKS): On 06/30/2011, Passport Capital reported holding 1,550,700 shares with a market value of $28,843,021. This comprised 1.83% of the total portfolio. On 09/30/2011, Passport Capital reported holding 1,556,900 shares with a market value of $23,742,725. This comprised 1.67% of the total portfolio. The net change in shares for this position over the two quarters is 6,200. About Company: Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on the oral delivery of drugs, and the development of pharmaceutical products based on pulmonary drug delivery technologies.
  • Acorda Therapeutics Inc. (NASDAQ:ACOR): On 06/30/2011, Passport Capital reported holding 1,107,900 shares with a market value of $35,796,251. This comprised 2.27% of the total portfolio. On 09/30/2011, Passport Capital reported holding 1,112,200 shares with a market value of $22,199,511. This comprised 1.56% of the total portfolio. The net change in shares for this position over the two quarters is 4,300. About Company: Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.
  • Accuray Incorporated (NASDAQ:ARAY): On 06/30/2011, Passport Capital reported holding 1,164,096 shares with a market value of $9,324,409. This comprised 0.59% of the total portfolio. On 09/30/2011, Passport Capital reported holding 5,000,000 shares with a market value of $20,050,001. This comprised 1.41% of the total portfolio. The net change in shares for this position over the two quarters is 3,835,904. About Company: Accuray Inc. has developed an intelligent robotic radiosurgery system designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.

(Note: Data regarding Passport Capital’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet